Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)

Dianthus Therapeutics (DNTH) has 4 years of Revenue data on record, last reported at $396000.0 in Q3 2025.

  • For Q3 2025, Revenue fell 81.77% year-over-year to $396000.0; the TTM value through Sep 2025 reached $8.0 million, up 49.71%, while the annual FY2024 figure was $6.2 million, 120.63% up from the prior year.
  • Revenue reached $396000.0 in Q3 2025 per DNTH's latest filing, up from $193000.0 in the prior quarter.
  • Across five years, Revenue topped out at $6.2 million in Q4 2024 and bottomed at $193000.0 in Q2 2025.
  • Average Revenue over 4 years is $1.4 million, with a median of $962000.0 recorded in 2023.
  • Peak YoY movement for Revenue: surged 1363.62% in 2024, then tumbled 89.64% in 2025.
  • A 4-year view of Revenue shows it stood at $1.2 million in 2022, then tumbled by 63.21% to $426000.0 in 2023, then soared by 1363.62% to $6.2 million in 2024, then crashed by 93.65% to $396000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $396000.0 in Q3 2025, $193000.0 in Q2 2025, and $1.2 million in Q1 2025.